Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzena Dworacka

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Disease Markers|November 9, 2005
The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patientsMarzena Dworacka, Hanna Winiarska
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|March 5, 2017
[Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy]Marzena Dworacka, Tamara Nowocień
European Journal of Pharmacology|July 2, 2021
Sirtuin 1 as the mechanism of action of agents used in the diabetes mellitus pharmacotherapyAgnieszka Stelmaszyk, Przemysław Mikołajczak, Marzena Dworacka
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 27, 2017
[Ibrutinib - new tool in hematologist hand, new challenges for internist]Maciej Majcherek, Marzena Dworacka, Grzegorz Dworacki
Diabetes Research and Clinical Practice|January 9, 2007
Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patientsMarzena Dworacka, Hanna Winiarska, Paweł P Jagodziński
Acta Biochimica Polonica|December 10, 2017
Homocysteine as a non-classical risk factor for atherosclerosis in relation to pharmacotherapy of type 2 diabetes mellitusMagdalena Borowska, Marzena Dworacka, Hanna Winiarska, et al.
Cytokine|April 10, 2008
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureasMałgorzata Wegner, Hanna Winiarska, Teresa Bobkiewicz-Kozłowska, et al.
Journal of Basic and Clinical Physiology and Pharmacology|April 3, 2003
Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patientsMarzena Dworacka, Hanna Winiarska, Malgorzata Szymańska, et al.
Ginekologia Polska|September 18, 2015
Family, anthropometric and biochemical factors affecting birth weight of infants born to GDM womenPatrycja Swierzewska, Marcin Kosiński, Marzena Wójcik, et al.
European Cytokine Network|November 7, 2014
Increased circulating RANTES in type 2 diabetesMarzena Dworacka, Ewa Krzyżagórska, Saule Iskakova, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Disease Markers|November 9, 2005
The application of plasma 1,5-anhydro-D-glucitol for monitoring type 2 diabetic patientsMarzena Dworacka, Hanna Winiarska
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|March 5, 2017
[Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy]Marzena Dworacka, Tamara Nowocień
European Journal of Pharmacology|July 2, 2021
Sirtuin 1 as the mechanism of action of agents used in the diabetes mellitus pharmacotherapyAgnieszka Stelmaszyk, Przemysław Mikołajczak, Marzena Dworacka
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|March 27, 2017
[Ibrutinib - new tool in hematologist hand, new challenges for internist]Maciej Majcherek, Marzena Dworacka, Grzegorz Dworacki
Diabetes Research and Clinical Practice|January 9, 2007
Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patientsMarzena Dworacka, Hanna Winiarska, Paweł P Jagodziński
Acta Biochimica Polonica|December 10, 2017
Homocysteine as a non-classical risk factor for atherosclerosis in relation to pharmacotherapy of type 2 diabetes mellitusMagdalena Borowska, Marzena Dworacka, Hanna Winiarska, et al.
Cytokine|April 10, 2008
IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureasMałgorzata Wegner, Hanna Winiarska, Teresa Bobkiewicz-Kozłowska, et al.
Journal of Basic and Clinical Physiology and Pharmacology|April 3, 2003
Serum N-epsilon-(carboxymethyl)lysine is elevated in nondiabetic coronary heart disease patientsMarzena Dworacka, Hanna Winiarska, Malgorzata Szymańska, et al.
Ginekologia Polska|September 18, 2015
Family, anthropometric and biochemical factors affecting birth weight of infants born to GDM womenPatrycja Swierzewska, Marcin Kosiński, Marzena Wójcik, et al.
European Cytokine Network|November 7, 2014
Increased circulating RANTES in type 2 diabetesMarzena Dworacka, Ewa Krzyżagórska, Saule Iskakova, et al.
Pageof 3